Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

sheeba farhat

Sheeba Farhat Joined Medical Dialogues in 2018 to report on the latest Education news. A Graduate of the University of Delhi, she specializes in covering stories related to Medical Education updates. For inquiries or further information, you can reach her at [email protected].

Home

sheeba farhat

Articles By : sheeba farhat

Drug regulator oversight sought for nutraceuticals; NGO flags quality, pricing concerns

Gujarat NGO Flags 'Regulatory Gaps' in Nutraceuticals, Seeks Drug-Level Control

Written By sheeba farhat20 April 2026 10:13 PM IST

New Delhi: A Gujarat-based NGO has urged the government to bring nutraceuticals, including fortified foods and health supplements, under the ambit of...

Rusan Pharma Achieves Global GMP Milestone with PMDA Japan Approval

Rusan Pharma Achieves Key GMP Clearance from Japan's PMDA

Written By sheeba farhat20 April 2026 7:30 PM IST

Mumbai: Rusan Pharma, a leading pharmaceutical company pioneering pain management, movement disorder, and addiction solutions worldwide, has achieved...

Eli Lilly to Acquire Ajax Therapeutics in USD 2.3 Billion Cancer Drug Push

Eli Lilly Nears $2 Billion Deal to Buy Kelonia Therapeutics

Written By sheeba farhat20 April 2026 5:00 PM IST

New Delhi: The U.S. drugmaker Eli Lilly, opens new tab, is in advanced talks to acquire biotech firm Kelonia Therapeutics for more than $ 2 ‌billion,...

Lilly's Foundayo Clocks 1,390 Prescriptions in Debut Week as Oral Obesity Drug Race Heats Up

Written By sheeba farhat19 April 2026 12:09 PM IST

New Delhi: Eli Lilly's newly launched weight-loss pill was prescribed 1,390 ‌times in the U.S. in its first week of sales, according to analysts who...

Aurobindo Pharma Gets USFDA Nod for OTC Dextromethorphan Polistirex ER Suspension

Written By sheeba farhat18 April 2026 7:40 PM IST

New Delhi: Aurobindo Pharma Limited has received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market...

GST 2.0 Strains FMCG, OTC Pharma as Inverted Duty, Cess Credits Hit Margins

Written By sheeba farhat18 April 2026 7:28 PM IST

New Delhi: The inverted duty structure resulting from rate changes under the Goods and Services Tax (GST) 2.0 regime is hurting companies especially...

No False Advertising Found: US Court Rejects Bayer Plea to Block Erleada Ads

No False Advertising Found: US Court Rejects Bayer Plea to Block Johnson and Johnson's Erleada Ads

Written By sheeba farhat18 April 2026 7:22 PM IST

New York: A U.S. judge has rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that its...

Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry

Roche Restarts Phase III Trial for Elevidys to Secure EMA Approval

Written By sheeba farhat17 April 2026 4:14 PM IST

New Delhi: Roche on Thursday said it is initiating a late stage study for its gene therapy Elevidys following feedback from the European drug...

OpenAI Unveils GPT-Rosalind, Expands AI Push into Biotech and Pharma R&D

Written By sheeba farhat17 April 2026 10:30 AM IST

New Delhi: OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge and scientific research capabilities,...

Hetero Targets 1.5 Million Semaglutide Pens, Eyes 75+ Markets

Written By sheeba farhat16 April 2026 8:30 PM IST

Hyderabad: Hetero Labs, one of India's largest privately held drugmakers, aims to sell 1.5 million pens of generic weight-loss and diabetes drugs in...

USFDA to Review Peptide Compounding Ban, Advisory Panel Meet Set for July

Written By sheeba farhat16 April 2026 8:22 PM IST

Bengaluru: The U.S. Food and Drug Administration will convene a panel of outside advisers in July to consider whether licensed compounding...

US, Global Fund Scale Up Rollout of Lenacapavir Across 20+ Countries

Written By sheeba farhat16 April 2026 8:02 PM IST

New Delhi: The U.S. and the Global Fund to Fight AIDS, Tuberculosis and Malaria are stepping up efforts to broaden access to Gilead's HIV prevention...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok